BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36848916)

  • 1. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
    Wiersinga WM; Poppe KG; Effraimidis G
    Lancet Diabetes Endocrinol; 2023 Apr; 11(4):282-298. PubMed ID: 36848916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism.
    Chaker L; Cooper DS; Walsh JP; Peeters RP
    Lancet; 2024 Feb; 403(10428):768-780. PubMed ID: 38278171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthyroidism. Current treatment guidelines.
    Gittoes NJ; Franklyn JA
    Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthyroidism: A Review.
    Lee SY; Pearce EN
    JAMA; 2023 Oct; 330(15):1472-1483. PubMed ID: 37847271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotoxicosis.
    Franklyn JA; Boelaert K
    Lancet; 2012 Mar; 379(9821):1155-66. PubMed ID: 22394559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
    Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
    Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
    Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism.
    De Leo S; Lee SY; Braverman LE
    Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease in children.
    Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
    Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and multimodal therapy of hyperthyroidism].
    Palitzsch KD
    Internist (Berl); 2008 Dec; 49(12):1428, 1430-2, 1434-6. PubMed ID: 18946641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
    Kahaly GJ
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
    Díez JJ
    Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotoxicosis - investigation and management .
    Gilbert J
    Clin Med (Lond); 2017 Jun; 17(3):274-277. PubMed ID: 28572231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current questions of thyroid diseases in childhood].
    Ilyés I
    Orv Hetil; 2011 Apr; 152(16):617-27. PubMed ID: 21454178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
    Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
    Körber C; Schneider P; Körber-Hafner N; Hänscheid H; Reiners C
    Eur J Nucl Med; 2001 Sep; 28(9):1360-4. PubMed ID: 11585295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.